Geron (GERN) Q2 2026 Earnings Call Transcript
Steady2 outlets reported this in 2 reports over 2 days
Thu, 6 August 2026Sun, 9 August 2026
What it is about
Ahmed ElnawawiMichelle RobertsonJoseph EidGil BlumTara BancroftChinmaya RathEmily BodnarStephen WilleyHarout SemerjianDevelopment ExpensesNational Comprehensive Cancer NetworkManagement For Geron CorporationCorporate AffairsGeron Corporation Second QuarterMoffitt Cancer CenterGermanyFranceMicrosoftNvidiaGeron Corporation
Who published it, and when
original reportfirst to report
fool.com
yahoo.com
6 Aug, 04:08over 3 days9 Aug, 07:15
How it spread - 2 original reports
Thu, 6 August 2026
1 report- fool.com04:08first to report
RYTELO demand grew 5% as prescribing accounts hit 1,575 since launch.
Sun, 9 August 2026
1 report- yahoo.com07:15
In the second quarter of 2026, Geron Corporation reported revenue of US$57.48 million versus US$49.04 million a year earlier, a net loss of US$16.68 million, first-half revenue of US$109.32 million, and a reduced first-half net loss of US$20.32 million, while also filing a US$6.03 million common stock shelf registration for 4,500,000 shares tied to an ESOP. Investors now have an initial full-year 2026 view on RYTELO, with Geron guiding to net product revenue between US$220 million and US$240...